GABA

GABA is a small signaling molecule that carries both an amine group and a carboxylic acid group, but because the amine is not attached to the alpha carbon it is not one of the amino acids used to build proteins ^[2]. In the adult brain it is the principal inhibitory transmitter, providing the counterbalance to excitatory signaling and helping to set the overall tone of neural activity ^[2]. The body makes GABA mainly from the excitatory transmitter glutamate through the enzyme glutamate decarboxylase, a reaction that depends on vitamin B6 as a cofactor ^[2].

GABA was first prepared chemically in the late nineteenth century, but its importance in the nervous system only became clear in the mid-twentieth century, when researchers identified it in brain tissue around 1950 and then recognized it as the inhibitory "Factor I" of nervous tissue extracts later that decade ^[2]. It signals through two receptor families: the fast-acting GABA-A receptors, which are ligand-gated chloride channels, and the slower GABA-B receptors, which are G protein-coupled ^[2].

As a supplement, GABA is widely available in powders and capsules and is promoted for calmness, stress relief, and sleep ^[2]. The central puzzle is delivery: for decades GABA was considered unable to cross the blood-brain barrier, and reviews note that the human evidence on this point is mixed and often comes from studies with commercial ties ^[2]. Small human trials have nonetheless reported measurable effects, such as a shift toward alpha brain-wave activity and lower stress markers after intake ^[1], and a placebo-controlled trial in sedentary women linked daily GABA to better sleep efficiency, improved mood, and higher heart-rate variability ^[4].

Where felt effects do occur, researchers suggest they may arise outside the brain, for example through GABA receptors in the gut and on the vagus nerve, which can relay signals to the brain; animal work shows dietary GABA activating vagal afferent nerves after a meal ^[3]. GABA is regulated as a food supplement in many countries and also occurs naturally in fermented foods; supplement material is produced either by bacterial fermentation or by chemical synthesis ^[2].

Oral GABA is generally regarded as safe and well tolerated, with occasional reports of tingling, flushing, or mild drops in blood pressure at higher doses. It is not associated with serious risks in typical supplemental amounts. Combining it with sedatives could theoretically add to relaxation.

Gamma-aminobutyric acid was identified in the mammalian brain in 1950, when Eugene Roberts and Sam Frankel at Washington University School of Medicine used newly developed chromatography to detect it in protein-free brain extracts and showed it is formed from glutamic acid. At nearly the same time Jorge Awapara independently reported the same unidentified amino acid, and several 1950 studies converged on GABA's abundance in amphibian and mammalian brain. Its function was long debated until 1957, when Canadian researchers showed that an inhibitory factor acting on crayfish neurons was in fact GABA, cementing its status as the central nervous system's principal inhibitory neurotransmitter. GABA is now sold as an over-the-counter supplement, though its ability to cross the blood-brain barrier when taken orally remains contested.